Bahnam P, Hanzel J, Ma C, Zou L, et al. Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies. J Crohns Colitis 2022 Oct 11. pii: 6758390. doi: 10.1093.
PMID: 36219564